Orthofix International | OFIX - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
EDAP TMS EUR -4.91M 597K 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -2.19M 20.07M 2025-12
Plus Therapeutics USD -5.71M 1.29M 2025-12
Smith & Nephew USD 469M 70M 2025-12
STAAR Surgical USD 18.79M 44.7M 2025-09
Stryker USD 1.7B 676M 2025-12
Surmodics USD -5.9M 1.61M 2025-06
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Veracyte USD 29.97M 10.66M 2026-03
Zimmer Biomet Holdings USD 98M 320.7M 2025-12